Search results
London stocks open nearly 1% higher, eye European rate cut; GSK slumps
Reuters via Yahoo News· 49 minutes agoGSK dropped 9.5% after a Delaware ruling allowed more than 70,000 lawsuits to proceed over its...
Dell Stock Tumbles After Earnings. Why Wall Street Is Staying Bullish, and Other Tech News Today
Barrons.com· 3 days agoShe maintained a Buy rating with a price target of $170 on the stock. J.P. Morgan Samik Chatterjee...
Zscaler (NASDAQ:ZS) Stock Rating Reaffirmed by JMP Securities
ETF DAILY NEWS· 1 day agoJMP Securities’ price objective would suggest a potential upside of 58.86% from the stock’s current price. A number of other research analysts have also recently issued reports ...
FY2024 EPS Estimates for Stoke Therapeutics, Inc. Lifted by Cantor Fitzgerald (NASDAQ:STOK)
ETF DAILY NEWS· 6 hours agoCantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings of ($2.35) per share for the year, up from their previous estimate of ($2.39). Cantor Fitzgerald currently ...
ChampionX Corp. [CHX] stock for 978,408 USD was sold by O’Dell William Jr. – Knox Daily
Knox Daily· 4 days agoOverweight” rating for CHX. Earlier on October 06, 2022, Barclays downgraded its rating. Their new recommendation was “an Equal weight” for CHX stock which ...
Deere & Company (NYSE:DE) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 6 hours agoDeutsche Bank Aktiengesellschaft cut their target price on Deere & Company from $425.00 to $401.00...
Piper Sandler analysts initates an Overweight rating for Taysha Gene Therapies Inc
Knox Daily· 5 days agoPiper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published on April 09, 2024; the price target was $9. A number of analysts ...
Piper Sandler initiates coverage of biotech stocks
Investing.com· 3 days agoPiper Sandler initiates coverage of biotech stocks
Inozyme Pharma stock rated Overweight by Wells Fargo, highlighting rare disease focus By...
Investing.com· 3 days agoOn Thursday, Wells Fargo (NYSE:WFC) initiated coverage on Inozyme Pharma Inc. (NASDAQ:INZY) stock,...
CIENA stock target cut, retains Overweight rating on slow telecom recovery By Investing.com
Investing.com· 4 days agoOn Thursday, JPMorgan (NYSE:JPM) revised its price target for CIENA Corp (NYSE: CIEN) shares to $60...